Excellence Begins Here

Board of Directors

Jack Ansell, MDAllison Burnett, PharmDDavid Garcia, MDScott Kaatz, DORenato Lopes, MD Edith Nutescu, PharmD

Lynn Oertel, RNMike Streiff, MDTerri Schnurr, RNDiane Wirth, ANPDaniel Witt, PharmDAnn Wittkowsky, PharmD

Mark Crowther, MD, President

Anticoagulation Forum• Founded almost 25 years ago by Jack Ansell• Largest organization for anticoagulation service

providers• Provide unbiased education to healthcare

professionals to improve patient care• Promote clinical application of evidence-based

practices• Our experts provide clarity and an authoritative

voice on the changing landscape of anticoagulation therapy

Who Are Our Members?

• Multidisciplinary membership – physicians, pharmacists, nurses

• Current membership: over 6,000• Number of clinics: 2,000• Number of patients reached: 750,000

Key Initiatives

• Biennial National Conference– April 23-25, 2015 in Washington, DC– Over 900 attendees– International expert faculty, posters, exhibits

• Anticoagulation Centers of Excellence – Roadmap for best practices – Rich library of current resources

• VTE Guidance Project• Monthly Webinars• Grand Rounds - AFib & VTE series at community-based hospitals • Boot Camps - Comprehensive basic training in anticoagulation

• Launched in December 2012, and our flagship program, ACE raises awareness & encourages clinical use of best practices and evidence-based guidelines, improving care for all patients on all antithrombotic medications.

• Website: excellence.acforum.org

How does ACE accomplish this goal?• Interactive assessment tool• Comprehensive Resource Center• Highlights clinics through “Examples of Excellence”

Anticoagulation Centers of Excellence

Grand Rounds

• Stroke Prevention in AFib– Round 1 – 16 live programs (975 total

attendees) and 1 enduring activity complete– Round 2 – 10 live programs, began Feb 2014

• Venous Thromboembolism– 20 live programs, began March 2014– 1 enduring activity, online through October

2015

VTE Guidance

• Publishing comprehensive consensus and evidence-based guidance for the treatment of VTE

• Being published mid-2015• Phase 2 will create slide decks and clinical

tools• Support

• Two-day conference for those new to the field of anticoagulation or want refresher course to bring them up to date on the changing practice of anticoagulation

• Miami, FL January, 2014• Seattle, WA October, 2014• Southwest location July 2015• East coast location October 2015

• Expert faculty, case-based learning, small personalized learning model

• Limited enrollment; all programs have sold out

November 2014 Webinar - National Assessment of Warfarin Anticoagulation Therapy for Stroke Prevention in Atrial Fibrillation; November 20, 2014 1:00 pm EST 2014: • Patient Webinar –DVT and PE Discussion in Honor of World Thrombosis Day• Antibiotic Interaction with Warfarin in the Ambulatory Setting• Dabigatran Plasma Concentrations, Ischemic Stroke & Major Bleeding in AFib• Review of RE-COVER I and II: FDA Approves use of Dabigatran for treatment of acute VTE• SOX Trial • COAG• BRUISE CONTROL• RE-ALIGN • Limited English Proficient Patients & Time in Therapeutic Range in a Warfarin Anticoag Clinic• Centers of Excellence

 2013: • ARISTOTLE – Apixaban v. warfarin for AFib• EINSTEIN – Rivaroxaban for VTE• PROTECT – Dalteparin v, unfractionated heparin in critically ill patients• Aspirin v. low molecular weight heparin after hip arthroplasty• FDA post marketing report on dabigatran• Inpatient consensus statement• CLOTS3 – pneumatic compression post stroke• Mgmt. and Outcomes – Major Bleeding with Dabigatran

 

National Action Plan for Adverse Drug Event Prevention

• US Dept. of Health & Human Services report focusing on Anticoagulant, Diabetes Agents, Opioids

• AC Forum highlighted as model for partnerships• Page 63 & 70 “Identify and promote adoption of standards that constitute

high-quality anticoagulation management e.g. Anticoagulation Centers of Excellence”

• Page 64 “Some organizations, such as the Anticoagulation Forum… are leading strategies that foster dissemination of best practices and prevention strategies across health care systems and facilities.”

• Page 68 “Public-private partnerships with organizations such as the Anticoagulation Forum, which also is facilitating widely and easily accessible formats for provider education aimed at improving the quality of anticoagulation care, could also be considered.”

Our Future

• Continuing our mission to educate healthcare providers to improve outcomes

• Embracing the changing landscape of anticoagulation

• Striving for outreach and collaboration in support of improved patient care